FloodLAMP - COVID-19 Tests Summary The FloodLAMP Biotechnologies one-page overview presents its low-cost, open-source molecular testing platform for infectious disease mass screening, combining an extraction-free colorimetric LAMP assay (QuickColor) and a higher-sensitivity RT-qPCR assay (EasyPCR) with a purpose-built digital system for pooled collection, accessioning, and reporting. It highlights claimed performance metrics (e.g., sensitivity/specificity and LoD), scaling advantages without capital-intensive instruments, and digital workflow features for participants and labs. It summarizes validation and regulatory posture (Stanford CLIA evaluation, EUAs and a pre-EUA submitted, IRB approval) and includes a clear statement that the tests were not FDA cleared/approved/authorized at the time. primary file various fl-presentations FloodLAMP - COVID-19 Tests Summary.md various/fl-presentations/FloodLAMP - COVID-19 Tests Summary.md 2021_05_20 pdf CC BY 4.0 - https://creativecommons.org/licenses/by/4.0/ 321 525 gfile-url xfile-github-download-url pdf-gdrive-url pdf-github-url github-markdown-url github-markdown-download-url web-pdf-url web-slides-url youtube-url web-url